Analyst Ratings for 4D Molecular Therapeutics (FDMT)
FDMT Rating Summary
FDMT Price Target Summary
- Highest: $38.00 (Goldman Sachs)
- Lowest: $17.00 (Leerink Partners)
- Average: $30.20
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$30.20 (+256.1%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
Avg. $ Target:
$30.20 (+256.1%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/28/2026 | Barclays | Eliana Merle | New Coverage | Overweight (N/A) |
33.00 (N/A) |
7.97 (8.48) |
6.4% | Details |
| 11/7/2025 | Morgan Stanley | Judah Frommer | Upgrade | Equalweight (Underweight) |
N/A (N/A) |
10.51 (8.48) |
-19.31% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
